Ruscitti, Piero http://orcid.org/0000-0003-3487-8551
Cipriani, Paola http://orcid.org/0000-0002-2000-4661
Liakouli, Vasiliki http://orcid.org/0000-0002-7392-9334
Iacono, Daniela http://orcid.org/0000-0002-3105-6096
Pantano, Ilenia
Caso, Francesco http://orcid.org/0000-0002-8928-2520
Perosa, Federico http://orcid.org/0000-0002-4072-4244
Atzeni, Fabiola http://orcid.org/0000-0002-9328-3075
Cantatore, Francesco Paolo http://orcid.org/0000-0001-9929-9177
Scarpa, Raffaele
Ciccia, Francesco http://orcid.org/0000-0002-9352-1264
Giacomelli, Roberto http://orcid.org/0000-0003-0670-9638
Article History
Received: 27 April 2019
Accepted: 22 June 2019
First Online: 1 July 2019
Compliance with ethical standards
:
: The authors declare that they have no conflicts of interest in this work. Piero Ruscitti: conflict of interest and relationships with pharma agencies—PR received speaker honoraria and/or grants from BMS, MSD, Ely Lilly, SOBI and Pfizer outside this work; Paola Cipriani: conflict of interest and relationships with pharma agencies—PC received speaker honoraria and/or grants from Actelion and Pfizer outside this work; Vasiliki Liakouli: conflict of interest and relationships with pharma agencies—VL received speaker honoraria and/or grants from Sanofi Genzyme and Pfizer outside this work; Daniela Iacono: conflict of interest and relationships with pharma agencies—DI received speaker honoraria from Pfizer, Sanofi Genzyme and BMS outside this work; Ilenia Pantano: conflict of interest and relationships with pharma agencies—none; Francesco Caso: conflict of interest and relationships with pharma agencies—none; Federico Perosa: conflict of interest and relationships with pharma agencies—none; Fabiola Atzeni: conflict of interest and relationships with pharma agencies—none; Francesco Paolo Cantatore: conflict of interest and relationships with pharma agencies—FPC received consultancy fees and/or speaker honoraria from Pfizer, Sanofi Genzyme and Roche outside this work; Raffaelle Scarpa: conflict of interest and relationships with pharma agencies—none; Francesco Ciccia: conflict of interest and relationships with pharma agencies—none; Roberto Giacomelli: conflict of interest and relationships with pharma agencies—RG received speaker honoraria and/or grants from Abbvie, Roche, Actelion, BMS, MSD, Ely Lilly, SOBI and Pfizer outside this work.
: All data relevant to the study are included in the article.